[EN] BISARYLSULFONAMIDES USEFUL AS KINASE INHIBITORS IN THE TREATMENT OF INFLAMMATION AND CANCER<br/>[FR] BISARYLSULFONAMIDES UTILISÉS COMME INHIBITEURS DE LA KINASE DANS LE TRAITEMENT DE L'INFLAMMATION ET DU CANCER
申请人:KANCERA AB
公开号:WO2011161201A1
公开(公告)日:2011-12-29
A compound of formula (I). The compound is useful for treating cancer and inflammatory diseases. A pharmaceutical composition containing the compound.
一种化合物的化学式(I)。该化合物可用于治疗癌症和炎症性疾病。含有该化合物的药物组合物。
[EN] PFKFB3 INHIBITORS AND THEIR USES<br/>[FR] INHIBITEURS DE PFKFB3 ET LEURS UTILISATIONS
申请人:GERO DISCOVERY LLC
公开号:WO2020080979A1
公开(公告)日:2020-04-23
This disclosure relates to new phthalimide and isoindolinone derivatives and other PFKFB3 inhibitors for use in the treatment of diseases. The invention further relates to pharmaceutical compositions containing such PFKFB3 inhibitors, methods of preparation thereof, methods for their use as therapeutic agents, and methods of preparation of a medicament for use in therapy, as well as kits and other inventiions comprising such PFKFB3 inhibitors. These PFKFB3 inhibitors are useful for the treatment and prophylaxis of cancer, neurodegenerative diseases, autoimmune diseases, inflammatory disorders, multiple sclerosis, metabolic diseases, inhibition of angiogenesis and other diseases and conditions, where the modulation of PFKFB3 and/or PFKFB4 has beneficial effect as well as neuroprotection.
Bisarylsulfonamides useful in the treatment of inflammation and cancer
申请人:Kancera AB
公开号:US10000449B2
公开(公告)日:2018-06-19
A compound of formula (I)
useful for the treatment of cancer, inflammation and inflammatory disorders, and a pharmaceutical composition containing the compound.
一种用于治疗癌症、炎症和炎症性疾病的式 (I) 化合物,以及一种含有该化合物的药物组合物。
US9718809B2
申请人:——
公开号:US9718809B2
公开(公告)日:2017-08-01
[EN] BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER<br/>[FR] BISARYLSULFONAMIDES UTILES DANS LE TRAITEMENT D'INFLAMMATIONS ET DE CANCER
申请人:KANCERA AB
公开号:WO2013093095A1
公开(公告)日:2013-06-27
A compound of formula (I), useful for the treatment of cancer, inflammation and inflammatory disorders, and a pharmaceutical composition containing the compound.